The U.S. FDA promotes an educational session on systems biology omics and biomarkers, reflecting ongoing agency emphasis on biomarker-driven evaluation and clinician education.
Join us for FDA Grand Rounds on April 9.
Dr. Richard Beger... will provide an overview of Systems Biology omics and biomarker concepts with four examples of omics analyses of human blood samples.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare